29.4 C
Delhi
Saturday, August 9, 2025

Elon Musk’s Neuralink gets FDA approval for in-human clinical study

Date:

Share post:

Donate-GC-Razorpay

Los Angeles: Neuralink, Elon Musk’s brain-machine interface company, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to conduct its first in-human clinical study.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company tweeted.

Neuralink said recruitment for its clinical trial “is not open yet.”

The FDA has not commented on the trial. And the extent of the approved trial is not known yet.

Neuralink was founded in 2016 and funded primarily by Musk to develop a new kind of interface technology between the human brain and computing devices.

Installing a chip in the human skull could restore limb function, improve human movement, resolve issues with eyesight and hearing, and help with diseases like Parkinson’s, the company claims.

Related articles

Trump to meet Putin in Alaska next week

Washington: US President Donald Trump has said he’ll be meeting with Russian President Vladimir Putin next Friday in...

Police Launch Widespread Crackdown on Banned Literature in Kashmir

The Jammu and Kashmir Police, on Thursday, said that they carried out coordinated and legally sanctioned searches at...

J&K Govt Bans 25 Books ‘Propagating False Narratives, Secessionism’

With its latest notification dated Tuesday, August 5, the Home Department, Government of Jammu and Kashmir, declared the...

Bandi Sanjay accuses Congress of betraying BCs while favouring Muslims

Hyderabad: Union Minister of State for Home Affairs Bandi Sanjay Kumar today accused the Congress party of deceiving...